Delivery Order SPE2DB25D2207-SPE2DB25FQREF
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $10,651.72 and is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $12,557.35 and a performance period ending on April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $12,154.60. It is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,810.69 and an ultimate completion date of April 8, 2025. The contract is for the supply of Myrbetriq ER 50 MG tablets, a medication used for the treatment of overactive bladder. The contract is not set aside for any specific business type. AmerisourceBergen holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $68,888.34 and is a firm fixed-price delivery order, with a performance period ending on May 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $3,572.77 and a period of performance through April 8, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen holds...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price of $2,169.52 and a completion date of July 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Myrbetriq ER 50 mg tablets, a medication used for the treatment of overactive bladder. The contract has a firm fixed-price, $34,152.51 ceiling value, and an ultimate completion date of February 21, 2024. This contract award is not associated with a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $14,356.96 and a period of performance through April 16, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 MG tablets, a medication used to treat overactive bladder. The contract is a firm fixed-price delivery order with a ceiling value of $2,423.21 and a period of performance through May 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQREFDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $9,435.77 and a period of performance through July 1, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 6/30/25 |